Topical corticosteroids may indirectly provide relief of itch associated with inflammatory skin diseases such as atopic dermatitis, but they should not be used to treat generalized itch.
Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...
Subject to FDA approval, VTAMA cream could become a compelling new treatment option for atopic dermatitis patients, most of whom regard itch as one of the most bothersome symptoms of their disease.” ...
The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...
Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...
Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...
Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...
The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.
Living with Atopic Dermatitis poses numerous ... With ongoing advancements in treatment options, there is renewed hope for a smoother, itch-free life and a brighter, healthier future!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback